BRAK LABS Peptide research, plainly written

compounds

Compounds

The whole category on one page, grouped by what people research each compound for, with the aliases that send readers to the wrong entry.

Last Reviewed Editorial policy Methodology

Every compound below is covered somewhere on this site, and the link on each row goes to where that coverage actually lives: a full evidence review where the published record carries one, or an entry inside the page for its category where it does not.

Coverage is tiered rather than uniform, and that is a deliberate choice with a measurement behind it. In this category the site that ranks best for the hardest term does it with roughly a quarter of the pages its nearest competitor runs. So a compound gets its own address when there is enough verified, sourced material to make that page worth landing on. Where the honest version would be three paragraphs and a table, it gets a few hundred properly cited words inside its category page instead, and the reader gets the same facts without the site carrying forty near-empty addresses.

Aliases are listed on every row because they are the commonest reason someone ends up reading about the wrong substance. Several compounds here are sold under invented names, some are blends named after their ingredients, and one of them is not a peptide at all.

Not medical advice

This page reports what has been documented about a compound. It is not medical advice, not a diagnosis, not a dosing protocol, and not a recommendation to obtain or use anything described here. Talk to a licensed clinician about anything concerning your health. Read the full disclaimer.

Reviewed against editorial standards Updated

Find a compound

51 compounds, grouped by what people research them for. The list below is complete without JavaScript. The search box appears when scripting is available, and it only filters what is already on the page.

Metabolic and weight loss

The gut-hormone copies and the compounds sold alongside them, each with the trials that tested it and the regulatory record behind it.

  • Semaglutide

    Also known as Ozempic, Wegovy, Rybelsus, Sema GLP-1

    A 31 amino acid analog of the gut hormone GLP-1, approved as a weight-loss and diabetes drug and also sold under invented names.

    Completed phase 3 programs Approved drugprovisional until its own review publishes

  • Tirzepatide

    Also known as Mounjaro, Zepbound, LY3298176, Tirz GLP-2

    A 39 amino acid molecule that acts at two gut hormone receptors at once, approved for weight loss and diabetes.

    Completed phase 3 programs Approved drugprovisional until its own review publishes

  • Retatrutide

    Also known as LY3437943, Reta GLP-3, GLP-3 RT

    A 39 amino acid molecule acting at three hormone receptors, still in trials and not approved anywhere.

    Phase 3 read out, not approved Investigationalprovisional until its own review publishes

  • Cagrilintide

    Also known as AM833, CagriSema (with semaglutide)

    A long-acting analog of amylin, a hormone released alongside insulin, studied mostly in combination rather than alone.

    Phase 3, mostly in combination Investigationalprovisional until its own review publishes

  • Survodutide

    Also known as BI 456906

    A molecule acting at two hormone receptors, GLP-1 and glucagon, in late-stage trials.

    Phase 3 read out Investigationalprovisional until its own review publishes

  • AOD-9604

    Also known as Anti-obesity drug 9604, hGH fragment 176-191

    The tail end of human growth hormone, a fragment of a molecule with a large clinical record that never tested the fragment.

    No registered trial under any spelling Unapprovedprovisional until its own review publishes

  • Tesofensine

    Also known as NS2330

    Not a peptide. A small molecule that blocks the reuptake of three brain chemicals, repurposed for weight loss after failing in Alzheimer's and Parkinson's.

    Phase 2 only Unapproved in the US

  • Mazdutide

    Also known as IBI362, LY3305677

    Another molecule acting at two hormone receptors, approved in China and covered almost nowhere in English.

    Phase 3 published, not reviewed here Approved in China

Healing and recovery

The compounds people research for tendon, muscle, joint, skin and gut repair, each with the species, the model and the study design behind it named.

  • KPV D Animals and anecdote

    Also known as Lysine-proline-valine, Lys-Pro-Val, alpha-MSH (11-13), MSH 11-13

    A three amino acid fragment of a hormone the body makes, studied as an anti-inflammatory agent in rodents and in cell culture.

    Graded, 32 numbered sources Not on the 503A Bulks List

  • BPC-157

    Also known as Body Protection Compound-157, PL 14736, Pentadecapeptide BPC

    A fifteen amino acid sequence derived from a protein found in human gastric juice, sold for injury recovery.

    Not reviewed on this site yet Was FDA 503A Category 2provisional until its own review publishes

  • TB-500

    Also known as Thymosin beta-4 fragment, TB-500 acetate

    A synthetic version of the active region of thymosin beta-4, an actin-binding protein, sold for injury recovery.

    Not reviewed on this site yet Unapproved. Named on the WADA listprovisional until its own review publishes

  • GHK-Cu B Human data, endpoint missed

    Also known as Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper, Copper peptide

    A three amino acid peptide bound to a copper ion, which occurs naturally in blood plasma and is sold both as a cosmetic ingredient and as an injectable.

    Graded, 29 sources. Both randomized trials came back level with control 503A category 1 for non-injectable routes; injectable withdrawn from category 2

  • Larazotide

    Also known as AT-1001, INN-202

    An eight amino acid peptide taken by mouth, developed for coeliac disease and now sold as a gut-health compound.

    Phase 3 discontinued Unapprovedprovisional until its own review publishes

  • ARA-290

    Also known as Cibinetide, Helix B surface peptide

    An eleven amino acid piece of erythropoietin, designed to keep the tissue-protective activity without raising red blood cell counts.

    Phase 2, narrow indications Unapprovedprovisional until its own review publishes

Growth hormone secretagogues

Nine compounds that raise growth hormone by acting on one of two receptors, including the only approved drug in the category and the one that is not a peptide.

  • Ipamorelin

    A five amino acid peptide that switches on the same receptor the hunger hormone ghrelin uses, prompting a release of growth hormone.

    Phase 2 discontinued Was FDA 503A Category 2provisional until its own review publishes

  • CJC-1295 without DAC

    Also known as Mod GRF 1-29, Modified GRF

    A 29 amino acid analog of the hormone that tells the pituitary to release growth hormone, sold as the default partner to ipamorelin.

    No trial under this name Unapprovedprovisional until its own review publishes

  • CJC-1295 with DAC

    Also known as Drug Affinity Complex, CJC-1295 DAC

    The same molecule as CJC-1295 with a linker attached that makes it bind to a blood protein and last far longer.

    Phase 2 halted Unapproved

  • Sermorelin

    Also known as GRF 1-29, Geref

    The first 29 amino acids of the hormone that triggers growth hormone release, once an approved medicine and now sold without one.

    Large diagnostic literature Approval withdrawn in 2008provisional until its own review publishes

  • Tesamorelin

    Also known as Egrifta, TH9507

    A stabilised analog of the growth-hormone-releasing hormone, and an approved drug for a specific condition.

    Approved for a narrow indication Approved drugprovisional until its own review publishes

  • Hexarelin

    Also known as Examorelin

    A six amino acid peptide at the same receptor as ipamorelin, producing the strongest growth hormone pulse of its group.

    No registered trials Unapproved

  • GHRP-2

    Also known as Pralmorelin

    A six amino acid peptide at the ghrelin receptor, approved in Japan as a single-dose diagnostic test rather than as a treatment.

    No registered trials Diagnostic approval in Japan

  • GHRP-6

    A six amino acid peptide at the ghrelin receptor whose most reliably documented effect, in rats, is a sharp rise in appetite.

    Animal data only Unapproved

  • MK-677

    Also known as Ibutamoren, Nutrobal, MK-0677

    Not a peptide. A small molecule taken by mouth that mimics ghrelin, developed by a major manufacturer and then abandoned.

    Trials completed, results adverse Unapproved. Not a peptideprovisional until its own review publishes

Longevity

Six compounds sold for ageing and mitochondrial health, including one approved drug, two molecules that are not peptides, and two whose trial counts measure rather than administer.

  • Epitalon

    Also known as Epithalon, Epithalamin, AEDG peptide

    A four amino acid peptide made to mimic an extract of the pineal gland, sold for ageing and sleep.

    Not reviewed on this site yet Unapprovedprovisional until its own review publishes

  • MOTS-c

    Also known as Mitochondrial ORF of the 12S rRNA type-c

    A sixteen amino acid peptide encoded by mitochondrial DNA rather than by the DNA in the cell nucleus.

    Not reviewed on this site yet Named on the WADA listprovisional until its own review publishes

  • SS-31

    Also known as Elamipretide, MTP-131, Bendavia, Forzinity

    A four amino acid peptide that concentrates in mitochondria, approved in 2025 for one rare condition.

    Not reviewed on this site yet Approved in 2025 for one conditionprovisional until its own review publishes

  • NAD+

    Also known as Nicotinamide adenine dinucleotide, NAD

    Not a peptide. A dinucleotide coenzyme every cell uses, sold as an injectable and, separately and lawfully, as an oral supplement.

    Not reviewed on this site yet Injectable form unapprovedprovisional until its own review publishes

  • 5-Amino-1MQ

    Also known as 5-amino-1-methylquinolinium

    Not a peptide. A small molecule that blocks an enzyme involved in how cells use NAD+.

    No registered trials Unapproved. Not a peptide

  • Humanin

    Also known as HN, HNG, S14G-humanin

    A 24 amino acid peptide, also encoded by mitochondrial DNA, sold on the same reasoning as MOTS-c.

    Registrations all observational Unapproved

Cognitive and sleep

Six compounds sold for focus, memory, calm and sleep, each with the published record behind it named and graded.

  • Semax

    Also known as N-acetyl semax amidate, NASA, ACTH (4-10) analog

    A seven amino acid peptide built from a piece of a stress hormone, with the hormonal activity removed.

    Not reviewed on this site yet A registered medicine in Russiaprovisional until its own review publishes

  • Selank

    Also known as N-acetyl selank amidate, NAS, TP-7

    A seven amino acid peptide based on tuftsin, an immune-signalling fragment, sold for anxiety.

    Registrations mostly non-interventional A registered medicine in Russiaprovisional until its own review publishes

  • Cerebrolysin

    Also known as FPF-1070

    A mixture of small peptides and amino acids prepared from pig brain tissue, rather than a single defined peptide.

    Reviewed repeatedly, results negative Unapproved in the USprovisional until its own review publishes

  • Dihexa

    Also known as PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

    A small analog of angiotensin IV, a fragment of a blood-pressure hormone, sold for cognition.

    No human studies. Mechanism paper retracted Unapprovedprovisional until its own review publishes

  • P21

    Also known as P021, Cnt-2-Ada

    A four amino acid derivative of a fragment of a nerve growth factor, studied only in rodents.

    No human data Unapproved

  • DSIP

    Also known as Delta sleep-inducing peptide, Emideltide

    A nine amino acid peptide isolated from rabbit brain in 1977 and sold for sleep.

    No registered trials Unapproved

Immune

Three compounds sold for immune function, separated by name, by evidence base, and by whether anyone has actually given them to a person.

  • Thymosin alpha-1

    Also known as Thymalfasin, Zadaxin, Talpha1

    A 28 amino acid peptide first isolated from thymus tissue, approved as a medicine in many countries but not in the United States.

    Not reviewed on this site yet Approved outside the USprovisional until its own review publishes

  • Thymulin

    Also known as Zinc-thymulin, FTS, Facteur thymique serique

    A nine amino acid thymus hormone that needs zinc to work, with essentially no modern human record.

    One observational registration Unapproved

  • LL-37

    Also known as Cathelicidin, CAP-18, hCAP18 (104-140)

    A 37 amino acid antimicrobial peptide, the only one of its kind the human body makes.

    Registrations mostly observational Unapprovedprovisional until its own review publishes

Sexual health

Four melanocortin and reproductive compounds, including two approved drugs sold under research names for something the approval never covered.

  • PT-141

    Also known as Bremelanotide, Vyleesi

    A seven amino acid ring-shaped melanocortin agonist, and a breakdown product of melanotan II, approved in 2019 for one indication.

    Not reviewed on this site yet Approved drugprovisional until its own review publishes

  • Kisspeptin-10

    Also known as Metastin, KP-10

    A ten amino acid fragment of the product of the KISS1 gene, which sits at the top of the reproductive hormone cascade.

    Trials largely used a longer form Unapprovedprovisional until its own review publishes

  • Melanotan I

    Also known as Afamelanotide, Scenesse

    A thirteen amino acid analog of the hormone that drives pigmentation, approved as an implant for a rare light-sensitivity disorder.

    Approved for a rare condition Approved drug, sold otherwise

  • Melanotan II

    Also known as MT-2, MT-II

    A ring-shaped seven amino acid analog of the pigmentation hormone, less selective than melanotan I, sold for tanning.

    One controlled human study, one registration Multiple regulator warningsprovisional until its own review publishes

Muscle and performance

Growth factors and muscle-signal blockers, each set beside the molecule it gets confused with and the trials that belong to each one.

  • IGF-1 LR3

    Also known as Long R3 IGF-1, IGF-1 Long Arg3

    An 83 amino acid modified version of a natural growth factor, altered so that it evades the proteins that normally hold it inactive.

    No human trials of this form Unapproved. Native form approvedprovisional until its own review publishes

  • Follistatin-344

    Also known as FS-344, FST-344, Follistatin

    Not a peptide. A 344 amino acid glycoprotein that blocks a growth-limiting signal in muscle.

    Human data belongs to another product Unapproved biologicprovisional until its own review publishes

  • ACE-031

    Also known as Ramatercept, ActRIIB-Fc

    Not a peptide. An engineered protein that traps the signals limiting muscle growth, whose trial program was stopped for safety.

    Phase 2 terminated for safety Never approved, discontinued 2013provisional until its own review publishes

  • Myostatin inhibitors

    Also known as GDF-8 antagonists, Myostatin, GDF-8

    Not peptides. A family of antibodies and engineered proteins that block the signal limiting muscle growth, none of which has been approved anywhere.

    None approved anywhere Unapproved

Cosmetic peptides

Five topical peptides that are listed cosmetic ingredients rather than unapproved drugs, with the trial behind each one read in full.

  • Acetyl hexapeptide-8

    Also known as Argireline, Acetyl hexapeptide-3

    A six amino acid peptide applied to the skin, which interferes with the machinery nerve endings use to release their signal.

    Best trial small and unbalanced Listed cosmetic ingredientprovisional until its own review publishes

  • Palmitoyl pentapeptide-4

    Also known as Matrixyl, Matrixyl 3000, pal-KTTKS

    A short peptide with a fatty tail attached to help it cross skin, one of the most widely used cosmetic peptides there is.

    Best trial is manufacturer-run Listed cosmetic ingredient

  • Acetyl octapeptide-3

    Also known as SNAP-8

    An eight amino acid extension of Argireline, marketed as the stronger version of it.

    No standalone published trial Listed cosmetic ingredient

  • GHK-Cu, topical

    Also known as Copper tripeptide-1, Copper peptide serum

    The same copper-bound tripeptide sold as an injectable, in the form where it is a listed cosmetic ingredient rather than an unapproved drug.

    Two randomized trials, neither separating from control Listed cosmetic ingredient

  • Pentapeptide-3

    Also known as Vialox

    A five amino acid cosmetic peptide sold on the same muscle-relaxing reasoning as Argireline.

    Not reviewed on this site Listed cosmetic ingredient

Compounds that get mixed up with each other

Several of the names above belong to more than one substance, or to a substance that is a piece of something better studied. Each page below sets out what each one actually is, and why the two get confused. There are 20 of them.

  • TB-500 and thymosin beta-4 One name covers two molecules of very different size, and the clinical record quoted for the short one was produced by the long one, in a tissue nobody buys it for.
  • SS-31 and elamipretide Two names, two registry counts, and one molecule underneath both of them, with a trial history that is unusually complete and unusually easy to misread.
  • PT-141 and melanotan II A metabolite and the molecule it comes from, set out on what each one is and what has actually been published about it.
  • NAD+ and peptides NAD+ is a coenzyme built from two nucleotides, filed on peptide menus for reasons of commerce rather than chemistry, and the difference changes what its evidence base contains.
  • Semax and selank Two peptides of the same length from the same laboratory, built on unrelated starting fragments, and sold so consistently as a pair that their abbreviations have started trading places.
  • Sermorelin vs CJC-1295 Two products cut from the same hormone, sold under names that differ by one word, with published records of completely different sizes.
  • CJC-1295 vs CJC-1295 with DAC The same base peptide sold as two products, separated by a linker that decides how long it stays in blood and which one has a human record.
  • GHK-Cu topical vs injected The same copper-carrying tripeptide, sold two ways, sitting on opposite sides of the line between cosmetic law and drug law.
  • GHK-Cu vs Matrixyl Two lawful cosmetic ingredients, sold as rivals, with a shared chemical core sitting inside one of them.
  • Argireline vs SNAP-8 One cosmetic peptide built as an extension of another, sold on the same mechanism, with published records of very different sizes.
  • Thymosin alpha-1 and thymulin Two peptides made by the thymus, one carrying the deepest trial record in this catalog outside the metabolic group and the other carrying a nutrition literature, sold beside each other on the strength of a shared syllable.
  • Thymosin alpha-1 and thymosin beta-4 Two molecules that share a word because of where they were first isolated, with trial programmes in fields that do not touch: sepsis and infection for one, the surface of the eye for the other.
  • IGF-1 LR3 and mecasermin Two versions of one growth factor: the natural sequence, which is an approved medicine with a documented harm rate, and an engineered variant built to slip past the proteins that hold the natural one in check.
  • Follistatin-344 and follistatin gene therapy One name, two entirely different interventions: a protein sold in a vial, and a virus carrying a gene into a named muscle in a hospital. The published human results belong to the second.
  • MOTS-c and humanin Two peptides encoded by the mitochondrion's own DNA, with registry counts that describe measurement programmes rather than treatment programmes.
  • Dihexa and fosgonimeton The same proposed mechanism, characterised to two completely different depths, with every fact on both sides carrying a date and a document.
  • Kisspeptin-10 and kisspeptin-54 Two lengths of the same reproductive hormone, with the published human work split unevenly between them.
  • Melanotan I and melanotan II Two names one digit apart, attached to two molecules whose published records were built for entirely different questions.
  • AOD-9604 and growth hormone A short synthetic fragment set beside the 191 amino acid hormone it was cut from, with the registry and the labelling for each stated separately, because almost everything published belongs to one of them.
  • Ipamorelin, GHRP-2 and GHRP-6 Three short peptides acting at the same receptor, sold as near-substitutes, whose published records were built to answer three questions that have almost nothing to do with each other.

How to read a row

The letter beside a name is an evidence grade, and it appears only where this site has run its own source review on that compound. It is derived from the tiers on the individual claims on that compound's page rather than assigned here, so a grade on this index cannot disagree with the page behind it. Where no review has been run the row says so and shows no letter, because a grade this site has not derived is a grade it does not publish.

A grade describes how well studied a compound is. It is not a statement about whether anything happens, and it is not a recommendation. The methodology page sets out how the five claim tiers and the four grades are derived, and every tier chip on every page links back to its own definition there.

The regulatory note on each row is a pointer rather than the position itself. Agency status changes, and the dated version, with the document behind it, is on the page the row links to.